Marcelo C. Pasquini

Also affiliated with Medical College of Wisconsin

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile

0.447Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Real-world data for tisagenlecleucel in patients with R/R B-ALL: subgroup analyses from the CIBMTR registry

Blood Advances(2025)10.1182/bloodadvances.2025015881

Top 42%

0.447DataRank

Top 42%18 citations

Kevin J. Curran, Erin Hall, Amy K. Keating, Susanne H.C. Baumeister, Sarah Nikiforow +15 more

Papers

Driven by 46 papers — median percentile 58. Top paper: “Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma”.

Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma

New England Journal of Medicine(2022)10.1056/nejmoa2204925

N/A

6.2DataRank · unranked

474 citations

Susanna Jacobus, Edie Weller, Hani Hassoun, Sagar Lonial, Noopur Raje +51 more

Decrease post-transplant relapse using donor-derived expanded NK-cells

Leukemia(2021)10.1038/s41375-021-01349-4

N/A

2.5DataRank · unranked

104 citations

Piyanuch Kongtim, Doris Soebbing, Prashant Trikha, Gregory K. Behbehani, Gabriela Rondón +15 more

Adjuvant doxycycline to enhance anti-amyloid effects: Results from the dual phase 2 trial

EClinicalMedicine(2020)10.1016/j.eclinm.2020.100361

N/A

1.6DataRank · unranked

38 citations

Anikó Szabó, Kathryn E. Flynn, Binod Dhakal, Saurabh Chhabra, Marcelo C. Pasquini +3 more

Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19?

Blood(2020)10.1182/blood.2020006216

N/A

0.633DataRank · unranked

67 citations

Sarah Nikiforow, Michael K. Mansour, Zhen‐Huan Hu, Mary M. Horowitz, Marcie Riches +6 more

Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic Anemia

Biology of Blood and Marrow Transplantation(2020)10.1016/j.bbmt.2020.04.027

N/A

0.581DataRank · unranked

47 citations

Mei-Jie Zhang, Xiao-Ying Tang, Stephanie J. Lee, Ming-Wei Fei, Hai-Lin Wang +14 more

Impact of Pretransplantation Renal Dysfunction on Outcomes after Allogeneic Hematopoietic Cell Transplantation

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.02.030

N/A

0.494DataRank · unranked

26 citations

Ajoy Dias, Tao Wang, Caitrin Fretham, Saurabh Chhabra, Hemant S. Murthy +30 more

Real-world data for tisagenlecleucel in patients with R/R B-ALL: subgroup analyses from the CIBMTR registry

Blood Advances(2025)10.1182/bloodadvances.2025015881

Top 42%

0.447DataRank

Top 42%18 citations

Kevin J. Curran, Erin Hall, Amy K. Keating, Susanne H.C. Baumeister, Sarah Nikiforow +15 more

Real-world evidence of axicabtagene ciloleucel (Axi-cel) for the treatment of large B-cell lymphoma (LBCL) in the United States (US).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.7552

N/A

0.396DataRank · unranked

13 citations

Frederick L. Locke, Zhen‐Huan Hu, Tanya Siddiqi, Sairah Ahmed, Armin Ghobadi +15 more

Novel genetic variants associated with mortality after unrelated donor allogeneic hematopoietic cell transplantation

EClinicalMedicine(2021)10.1016/j.eclinm.2021.101093

N/A

0.385DataRank · unranked

12 citations

Junke Wang, Leah Preus, Ezgi Karaesmen, Abbas Rizvi, Alyssa Clay‐Gilmour +17 more

Pre-HCT mosaicism increases relapse risk and lowers survival in acute lymphoblastic leukemia patients post–unrelated HCT

Blood Advances(2021)10.1182/bloodadvances.2020003366

N/A

0.292DataRank · unranked

6 citations

Weiyin Zhou, Junke Wang, Ezgi Karaesmen, Hancong Tang, Philip L. McCarthy +20 more

Prognostic impact of pre-transplant chromosomal aberrations in peripheral blood of patients undergoing unrelated donor hematopoietic cell transplant for acute myeloid leukemia

Scientific Reports(2021)10.1038/s41598-021-94539-0

N/A

0.292DataRank · unranked

6 citations

Weiyin Zhou, Lisa J. McReynolds, Hormuzd A. Katki, Elizabeth A. Griffiths, Swapna Thota +23 more

Benefit of axicabtagene ciloleucel versus chemoimmunotherapy in older patients and/or patients with poor ECOG performance status with relapsed or refractory large B‐cell lymphoma after 2 or more lines of prior therapy

American Journal of Hematology(2024)10.1002/ajh.27283

N/A

0.241DataRank · unranked

4 citations

Hailin Wang, Zhen‐Huan Hu, Frederick L. Locke, Tanya Siddiqi, Caron A. Jacobson +18 more

Shared Graft Versus Leukemia Minor Histocompatibility Antigens in DISCOVeRY-BMT

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.08.12.503667

N/A

0.104DataRank · unranked

1 citations

Othmane Jadi, Sarah Dexheimer, Dante S. Bortone, Steven Vensko, Sarah Bennett +19 more

Trajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myeloma

American Journal of Hematology(2022)10.1002/ajh.26596

N/A

0DataRank · unranked

30 citations

Ruta Brazauskas, Edward A. Stadtmauer, Marcelo C. Pasquini, Parameswaran Hari, Asad Bashey +16 more

Noninfectious Pulmonary Toxicity after Allogeneic Hematopoietic Cell Transplantation

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.03.015

N/A

0DataRank · unranked

27 citations

Kwang Woo Ahn, Manoj Khanal, Caitrin Bupp, Mariam Allbee‐Johnson, Navneet S. Majhail +24 more

Progressive multifocal leukoencephalopathy in patients treated with chimeric antigen receptor T cells

Blood(2022)10.1182/blood.2022017386

N/A

0DataRank · unranked

12 citations

Emanuel Raschi, Joab Chapman, Bianca Santomasso, Marcelo C. Pasquini, Miguel‐Angel Perales +2 more

Shared graft-versus-leukemia minor histocompatibility antigens in DISCOVeRY-BMT

Blood Advances(2022)10.1182/bloodadvances.2022008863

N/A

0DataRank · unranked

10 citations

Othmane Jadi, Sarah Dexheimer, Dante S. Bortone, Steven Vensko, Sarah Bennett +19 more

A Multicenter Phase II, Double-Blind, Placebo-Controlled Trial of Maintenance Ixazomib After Allogeneic Transplantation for High-Risk Multiple Myeloma: Results of the Blood and Marrow Transplant Clinical Trials Network 1302 Trial

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.07.007

N/A

0DataRank · unranked

9 citations

T Nishihori, Marcelo C. Pasquini, Michael J. Martens, Juan Wu, Melissa Alsina +15 more

DNA methylation in circulating leukocytes is a novel biomarker in multiple myeloma

Bone Marrow Transplantation(2022)10.1038/s41409-022-01887-0

N/A

0DataRank · unranked

2 citations

Ruta Brazauskas, Bi Qing Teng, Grant Yun, Hannah Uttley, Jing Dong +8 more

Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple Myeloma

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.05.019

N/A

0DataRank · unranked

1 citations

Fotis Asimakopoulos, Abdel Kareem Azab, Giada Bianchi, Manisha Bhutani, Leslie Crews +18 more

Associations of Minor Histocompatibility Antigens with Clinical Outcomes Following Allogeneic Hematopoietic Cell Transplantation

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.08.31.506092

N/A

0DataRank · unranked

0 citations

Hancong Tang, Kelly Olsen, Steven Vensko, Qianqian Zhu, Yiwen Wang +13 more

Real-World Data Showing Trends and Outcomes by Race and Ethnicity in Allogeneic Hematopoietic Cell Transplantation: A Report from the Center for International Blood and Marrow Transplant Research

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.03.007

N/A

0DataRank · unranked

71 citations

Jianqun Kou, Min Chen, Yung‐Tsi Bolon, Larisa Broglie, Caitrin Bupp +23 more

Chimeric Antigen Receptor T Cell Therapy for Myeloma: Where Are We Now and What Is Needed to Move Chimeric Antigen Receptor T Cells Forward to Earlier Lines of Therapy? Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.10.022

N/A

0DataRank · unranked

42 citations

Binod Dhakal, Tania Jain, Olalekan O. Oluwole, Gunjan L. Shah, Surbhi Sidana +3 more

INSPIRED Symposium Part 1: Clinical Variables Associated with Improved Outcomes for Children and Young Adults treated with Chimeric Antigen Receptor T cells for B cell Acute Lymphoblastic Leukemia

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.07.016

N/A

0DataRank · unranked

10 citations

Elad Jacoby, Michael A. Pulsipher, Marcelo C. Pasquini, Stephan A. Grupp, Nirali N. Shah +4 more

Symptom clusters and their impact on quality of life in multiple myeloma survivors: Secondary analysis of BMT CTN 0702 trial

British Journal of Haematology(2024)10.1111/bjh.19326

N/A

0DataRank · unranked

9 citations

Kathryn E. Flynn, Amrita Krishnan, Heather Landau, Sergio Giralt, Marcelo C. Pasquini +3 more

Pathogenic and likely pathogenic germline variation in patients with myeloid malignancies and their unrelated HLA-matched hematopoietic stem cell donors

Journal of Translational Genetics and Genomics(2024)10.20517/jtgg.2023.31

N/A

0DataRank · unranked

2 citations

J. N. Cooper, Junke Wang, Qianqian Zhu, Loreall Pooler, Xin Sheng +9 more

Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19?

UNC Libraries(2024)10.17615/h0gs-sd07

N/A

0DataRank · unranked

1 citations

Michael K. Mansour, Zhen‐Huan Hu, Mary M. Horowitz, Peiman Hematti, Miguel‐Angel Perales +6 more

T-ICAHT: Grading and Prognostic Impact of Thrombocytopenia After CAR T-cell Therapy

Blood(2025)10.1182/blood.2025028833

N/A

0DataRank · unranked

34 citations

Jaime Sanz, Teng Fei, Monica Nair, Hamza Hashmi, Abraham Avigdor +32 more

Real-world outcomes with tisagenlecleucel in aggressive B-cell lymphoma: subgroup analyses from the CIBMTR registry

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2024-009890

N/A

0DataRank · unranked

14 citations

Matthew J. Frigault, Michael Heim, S.R. Foley, Brian T. Hill, Grant Schofield +14 more

New comorbidity index associated with survival after chimeric antigen receptor T-cell therapy for large B-cell lymphoma

Blood Advances(2025)10.1182/bloodadvances.2024015599

N/A

0DataRank · unranked

5 citations

Hamza Hashmi, Mahmoud Elsawy, Soyoung Kim, Amy Moskop, Temitope Oloyede +40 more

CRS or ICANS Are Rare Beyond 2 Weeks After Lisocabtagene Maraleucel Infusion: Data From Clinical Trials and the Real-World Setting

Transplantation and Cellular Therapy(2025)10.1016/j.jtct.2025.10.024

N/A

0DataRank · unranked

3 citations

Matthew A. Lunning, Mazyar Shadman, Sairah Ahmed, Jeremy S. Abramson, Miguel‐Angel Perales +14 more

143 | REAL‐WORLD OUTCOMES OF AXICABTAGENE CILOLEUCEL (AXI‐CEL) FOR THE TREATMENT OF RICHTER TRANSFORMATION TO LARGE B‐CELL LYMPHOMA (RT‐LBCL)

Hematological Oncology(2025)10.1002/hon.70093_143

N/A

0DataRank · unranked

1 citations

Constance Lau, Mazyar Shadman, Alex F. Herrera, Caron A. Jacobson, F. L. Locke +13 more

Current Use of and Trends in Hematopoietic Cell Transplantation in the United States

Biology of Blood and Marrow Transplantation(2020)10.1016/j.bbmt.2020.04.013

N/A

0DataRank · unranked

707 citations

Caitrin Fretham, Stephanie J. Lee, Mukta Arora, Janet Brunner, Saurabh Chhabra +16 more

Real-world outcomes of axicabtagene ciloleucel (axi-cel) for the treatment of relapsed/refractory (R/R) secondary central nervous system lymphoma (SCNSL).

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.7024

N/A

0DataRank · unranked

0 citations

Babatunde Adedokun, Hamza Hashmi, Mazyar Shadman, Allison Winter, Alex F. Herrera +14 more

Incidence, Risk Factors for and Outcomes of Transplant‐Associated Thrombotic Microangiopathy

British Journal of Haematology(2020)10.1111/bjh.16457

N/A

0DataRank · unranked

94 citations

Ang Li, Brent R. Logan, Caitrin Fretham, Saurabh Chhabra, Mahmoud Aljurf +15 more

Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trial

Blood Advances(2020)10.1182/bloodadvances.2019000765

N/A

0DataRank · unranked

51 citations

J. Douglas Rizzo, Parameswaran Hari, Marcelo C. Pasquini, Karen E. Giles, Anita D’Souza +9 more

Cancer Moonshot Immuno-Oncology Translational Network (IOTN): accelerating the clinical translation of basic discoveries for improving immunotherapy and immunoprevention of cancer

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-000796

N/A

0DataRank · unranked

13 citations

Andrew G. Sikora, Catherine M. Bollard, José R. Conejo-García, Carolina Colli Cruz, Shadmehr Demehri +21 more

Long-term survival of 1338 MM patients treated with tandem autologous vs. autologous-allogeneic transplantation

Bone Marrow Transplantation(2020)10.1038/s41409-020-0887-4

N/A

0DataRank · unranked

44 citations

Simona Iacobelli, Marcelo C. Pasquini, Riddhi Modi, Luisa Giaccone, Joan Bladé +13 more

Summary of the 2019 Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling

Biology of Blood and Marrow Transplantation(2020)10.1016/j.bbmt.2020.06.011

N/A

0DataRank · unranked

6 citations

Alan Howard, David Avigan, Manisha Bhutani, Adam D. Cohen, Luciano J. Costa +22 more

Long-term follow-up of BMT CTN 0702 (STaMINA) of postautologous hematopoietic cell transplantation (autoHCT) strategies in the upfront treatment of multiple myeloma (MM).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.8506

N/A

0DataRank · unranked

102 citations

Marcelo C. Pasquini, Edward A. Stadtmauer, Raphael Fraser, Mingwei Fei, Steven M. Devine +14 more

The IL-6 antagonist tocilizumab is associated with worse depression and related symptoms in the medically ill

Translational Psychiatry(2021)10.1038/s41398-020-01164-y

N/A

0DataRank · unranked

76 citations

Erin S. Costanzo, Suraj Singh, Ziyan Yin, Anikó Szabó, Deepa S. Pawar +9 more

Beyond the storm — subacute toxicities and late effects in children receiving CAR T cells

Nature Reviews Clinical Oncology(2021)10.1038/s41571-020-00456-y

N/A

0DataRank · unranked

68 citations

Juliane Gust, Agne Taraseviciute, Pamela L. Wolters, Allison Barz Leahy, Carlos Sandi +16 more

Impact of Conditioning Intensity and Genomics on Relapse After Allogeneic Transplantation for Patients With Myelodysplastic Syndrome

JCO Precision Oncology(2021)10.1200/po.20.00355

N/A

0DataRank · unranked

25 citations

Gege Gui, Brent R. Logan, Mingwei Fei, Jack Ghannam, Yuesheng Li +17 more

Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021: Looking Forward as the Network Celebrates its 20th Year

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.08.016

N/A

0DataRank · unranked

18 citations

Edward A. Stadtmauer, John E. Levine, Karen K. Ballen, Yi‐Bin Chen, Amy E. DeZern +20 more

The 2020 BMT CTN Myeloma Intergroup Workshop on Immune Profiling and Minimal Residual Disease Testing in Multiple Myeloma

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.05.027

N/A

0DataRank · unranked

3 citations

Nizar J. Bahlis, P. Leif Bergsagel, Manisha Bhutani, Niccolò Bolli, Carrie Brownstein +18 more

The results of multicenter phase II, double-blind placebo-controlled trial of maintenance ixazomib after allogeneic hematopoietic cell transplantation (alloHCT) for high-risk multiple myeloma (MM) from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 1302).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.7003

N/A

0DataRank · unranked

2 citations

Qaiser Bashir, Marcelo C. Pasquini, Michael J. Martens, Juan Wu, Melissa Alsina +11 more

Marcelo C. Pasquini

Indexed papers

Top data-sharing exemplar

Papers